Genetic Technologies: New Risk Tests for Breast and Colorectal Cancers

May. 10, 2019
Exclusive interview with Paul Kasian, Chairman & CEO of Genetic Technologies (NASDAQ: GENE). GENE is a diversified molecular diagnostics company ...

 Read More


"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market